Improper Inhaler Use Can Affect Asthma Control

Inhaler mistakes are more common than you might think. Up to 92% of people with asthma use their device incorrectly. If your medicine isn’t reaching your lungs, your asthma might be harder to control. Lesen Sie weiter auf: Improper Inhaler Use Can Affect Asthma Control Quelle: Asthma and Allergy Foundation of America Titelbild/Grafik by Asthma […]

…/Auszug

New Digital Long-Term Control Inhaler Works With Smartphones to Help People Track Inhaler Use

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, a combination therapy digital inhaler with built-in sensors that connects to a companion mobile application to provide information on inhaler use to people […]

…/Auszug

Asthma and Allergy Foundation of America Responds to Premature ICER Review of New Peanut Allergy Treatments

The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access […]

…/Auszug

FDA Approves Dupixent® for Chronic Rhinosinusitis With Nasal Polyps

The U.S. Food and Drug Administration today approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity). This is the first treatment approved for inadequately controlled chronic rhinosinusis with nasal polyps… Lesen Sie weiter auf: FDA […]

…/Auszug